Main Article Content
Abstract
The article describes a rare clinical case of Lyell's syndrome in a patient with a malignant neoplasm of the sigmoid colon with bilobar metastases to the liver, a history of palliative resection of the sigmoid colon, who was prescribed therapy with the BRAF inhibitor Vemurafenib. While taking the drug, toxic epidermal necrolysis, a generalized form, developed. Toxic epidermal necrolysis (TEN, Lyell's syndrome) is an acute, life-threatening mucocutaneous reaction characterized by skin tenderness, erythema, extensive necrosis and epidermal detachment. The incidence rate is from 0.4 to 1.2 cases per million person-years and mortality up to 50 %. Representatives of the female sex are more often affected. The incidence increases with age and is higher after the fourth decade of life.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Bašković M, Barčot Z, Šoša DŠ, Ježek D, Župančić B. 338 Lyell’s syndrome – potentially life-threatening mucocutaneous disease. BMJ Case Reports. 2020; 13 (10): e237891. doi: 10.1136/bcr-2020-237891
Schneider JA, Cohen PR. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. Adv Ther. 2017; 34(6): 1235-1244. doi: 10.1007/s12325-017-0530-y
E`sedov E`M, Axmedova FD, Akbieva DS. Toksicheskij e`pidermal`ny`j nekroliz v praktike semejnogo vracha. Spravochnik vracha obshhej praktiki. 2020; (1): 61-67. Russian (Эседов Э.М., Ахмедова Ф.Д., Акбиева Д.С. Токсический эпидермальный некролиз в практике семейного врача //Справочник врача общей практики. 2020. № 1. С. 61-67.) doi: 10.33920/med-10-2001-09
Lerch M, Mainetti C, Beretta-Piccoli BT, Harr T. Current perspectives on Stevens-Johnson Syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018; 54(1): 147-176. doi: 10.1007/s12016-017-8654-z
Tseng J, Maurer T, Mutizwa MM. HIV-associated toxic epi-dermal necrolysis at San Francisco General Hospital. J Int Assoc Provid AIDS Care. 2017; 16(1): 37-41. doi: 10.1177/2325957415614651
Nunes JM, Santareno S, Guerreiro L, Margalh AF. Lyell's Syndrome and Antimalarials: A Case Report and Clinical Review. J Glob Infect Dis. 2017; 9(1): 23-30. doi: 10.4103/0974-777X.199994
Zimina LN, Ibraeva AI, Mikhailova GV, Osipenkova-Vichtomova TK, Strokova VA, Titova VV. Lyell’s Syndrome in medico-legal and pathological-anatomical practice. Russian Sklifosovsky Journal «Emergency Medical Care». 2016; (2): 64-68. Russian (Зимина Л.Н., Ибраева А.И., Михайлова Г.В., Осипенкова-Вичтомова Т.К., Строкова В.А., Титова В.В. Синдром Лайелла в судебно-медицинской и патолого-анатомической практике //Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь». 2016. № 2. С. 64-68)
Popova DM, Voznesensky SL, Soboleva ZA Toxic epidermal necrolysis (Lyell’s syndrome) in a patient with HIV infection. Epidemiology and infectious diseases. 2020; 25(4): 174-182. Russian (Попова Д.М., Вознесенский С.Л., Соболева З.А. Токсический эпидермальный некролиз (синдром Лайелла) у пациента с ВИЧ-инфекцией //Эпидемиология и инфекционные болезни. 2020. Т. 25, № 4. С. 174-182.) doi: 10.17816/EID54469
Strużyna J, Surowiecka A, Korzeniowski T, Piszczek J, Korulczyk P, Drozd L, et al. Immunomodulatory Treatment of Lyell's Syndrome: A Simultaneous Plasmapheresis and Intravenous Immunoglobulins Therapy. J Burn Care Res. 2022; 43(6): 1394-1398. doi: 10.1093/jbcr/irac046
Connelly-Smith L, Alquist CR, Aqui NA, Hofmann JC, Klingel R, Onwuemene OA, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue. J Clin Apher. 2023; 38(2): 77-278. doi: 10.1002/jca.22043
Barron SJ, Del Vecchio MT, Aronoff SC. Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies. Int J Dermatol. 2015; 54(1): 108-115. doi: 10.1111/ijd.12423
Lee HY, Fook-Chong S, Koh HY, Thirumoorthy T, Pang SM. Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center. J Am Acad Dermatol. 2017; 76(1): 106-113. doi: 10.1016/j.jaad.2016.07.048